These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33387252)

  • 1. QTc Prolongation in COVID-19 Patients Using Chloroquine.
    Becker ML; Snijders D; van Gemeren CW; Kingma HJ; van Lelyveld SFL; Giezen TJ
    Cardiovasc Toxicol; 2021 Apr; 21(4):314-321. PubMed ID: 33387252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients.
    Bakhshaliyev N; Uluganyan M; Enhos A; Karacop E; Ozdemir R
    J Electrocardiol; 2020; 62():59-64. PubMed ID: 32827987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.
    Heemskerk C; Woldman E; Pereboom M; Van der Hoeven R; Mantel-Teeuwisse A; Van Gemeren C; Becker ML
    J Pharm Pharm Sci; 2017; 20(1):360-364. PubMed ID: 29145929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.
    Ding J; Liu W; Guan H; Feng Y; Bao Y; Li H; Wang X; Zhou Z; Chen Z
    Medicine (Baltimore); 2021 Jul; 100(28):e26538. PubMed ID: 34260531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for QTc interval prolongation.
    Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.
    Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
    O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
    JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No QTc Prolongation in Girls and Women with Turner Syndrome.
    Noordman ID; Duijnhouwer AL; Coert M; Bos M; Kempers M; Timmers HJLM; Fejzic Z; van der Velden JAEM; Kapusta L
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4148-56. PubMed ID: 32838426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
    Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
    JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
    Uğurlu Ilgın B; Akbulut Koyuncu İM; Kızıltunç E
    Anatol J Cardiol; 2021 Mar; 25(3):184-190. PubMed ID: 33690133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of corrected QT interval in pediatric genotyped long QT syndrome.
    Ogawa Y; Tanaka T; Kido S
    Pediatr Int; 2016 Nov; 58(11):1246-1248. PubMed ID: 27882731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QTc abnormalities in deliberate self-poisoning with moclobemide.
    Downes MA; Whyte IM; Isbister GK
    Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction.
    Christensen TF; Tarnow L; Randløv J; Kristensen LE; Struijk JJ; Eldrup E; Hejlesen OK
    Diabetologia; 2010 Sep; 53(9):2036-41. PubMed ID: 20496052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
    Koh HM; Chong PF; Tan JN; Chidambaram SK; Chua HJ
    J Clin Pharm Ther; 2021 Jun; 46(3):800-806. PubMed ID: 33768612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
    Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ
    Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.
    Sinkeler FS; Berger FA; Muntinga HJ; Jansen MMPM
    Neth Heart J; 2020 Jul; 28(7-8):418-423. PubMed ID: 32648153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.